含有二糖结构的核苷类似物的合成

利用Ferrier重排反应合成了两个系列的连有核音的2,3-不饱和糖苷(其中核耷包括尿苷、腺苷、肌苷等).这些新化合物的结构通过NMR和MS(HRFAB)得到证实.     

Synthesis of Novel 1,3-Dioxolane Nucleoside Analogues

Novel 1,3-dioxolane C-nucleoside analogues of tiazofurin 2-(2-hydroxymethyl-1,3-dioxolan-4-yl)-1,3-thiazole4-carboxamide as well as N-nucleoside analogues of substituted imidazoles 1-(2-hydroxymethyl-1,3-dioxolan4-yl)-4-nitroimidazole and 1-(2-hydroxymethyl-1,3-dioxolan-4-yl)-4,5-dicyanoimidazole were synthesized from methyl acrylate through a multistep procedure. Their structures were confirmed by IR,^1H NMR,^13C NMR spectraand elemental analysis.     

Efficient Synthesis of New Nucleoside Analogues with a Methylenecyclobutane Unit

Synthesis of eight nucleoside analogues 4–11 with a methylenecyclobutane unit is described. Wittig reaction with 2‐hydroxymethylcyclobutanone 12 gave a mixture of Z (13) and E (14) derivatives, which was separated before functional modifications. The heterocyclic moieties were introduced via a Mitsunobu reaction either on the saturated chain or on the unsaturated chain. When adenine was used in this reaction, only the N‐9 substitution products were obtained. Removal of the protecting groups provided the target products.     

离子液体中核苷类似物的化学合成

核苷类似物因其显著的抗病毒、抗肿瘤活性,已作为化疗药物在临床上得到了广泛应用.核苷类似物的高效绿色合成是有机化学和药物化学领域的重要课题.本文对近年来离子液体介质中的核苷改造进行了综述,主要包括羟基和氨基的保护、糖基的改造、碱基的改造、糖基与碱基的耦合和寡核苷酸的合成.离子液体作为一类物理化学性能可设计的绿色软介质...     

Synthesis of Methylenecyclopropane Analogues of Antiviral Nucleoside Phosphonates

Synthesis of methylenecyclopropane analogues of nucleoside phosphonates 6a, 6b, 7a and 7b is described. Cyclopropyl phosphonate 8 was transformed in four steps to methylenecyclopropane phosphonate 16. The latter intermediate was converted in seven steps to the key Z- and E-methylenecyclopropane alcohols 23 and 24 separated by chromatography. Selenoxide eliminations (15→16 and 22→23+24) were instrumental in the synthesis. The Z- and E-isomers 23 and 24 were transformed to bromides 25a and 25b, which were used for alkylation of adenine and 2-amino-6-chloropurine to give intermediates 26a, 26b, 26c and 26d. Acid hydrolysis provided the adenine and guanine analogues 6a, 6b, 7a and 7b. Phosphonates 6b and 7b are potent inhibitors of replication of Epstein-Barr virus (EBV).     

Synthesis and Biological Activity of a Series of Methylene-Expanded Oxetanocin Nucleoside Analogues

Summary.  A series of methylene-expanded oxetanocin nucleoside analogues, e.g. analogues of 2 and the known antiviral nucleosides AZT, FLT, and ddC (3) were prepared by a very direct route beginning with the readily available (S )-glycidol 4 and proceeding via the dihydrofuran-3-methanols 9a,b. Biological testing of these modified nucleosides indicates that they are non-cytotoxic compounds with generally weak antiviral activity. However, the guanosine analogue 2G showed pronounced activity vs. herpes simplex virus type 1 (HSV-1) in cell culture and was HSV-1-encoded thymidine kinase dependent. This compound is therefore an interesting new lead structure for the development of new anti-HSV agents. Received September 3, 2001. Accepted September 17, 2001     

微波在核苷类化合物合成中的应用

核苷类化合物由于其显著的抗病毒、抗癌等生理活性而受到广泛关注. 利用微波促进核苷类化合物的合成与传统合成方法相比, 有明显的优势. 对近年来微波在核苷类化合物合成中的应用进行综述, 着重介绍了微波作用于几种重要核苷类化合物合成反应类型的研究状况.     

Membrane‐permeable Triphosphate Prodrugs of Nucleoside Analogues

The metabolic conversion of nucleoside analogues into their triphosphates often proceeds insufficiently. Rate‐limitations can be at the mono‐, but also at the di‐ and triphosphorylation steps. We developed a nucleoside triphosphate (NTP) delivery system (TriPPPro‐approach). In this approach, NTPs are masked by two bioreversible units at the γ‐phosphate. Using a procedure involving H‐phosphonate chemistry, a series of derivatives bearing approved, as well as potentially antivirally active, nucleoside analogues was synthesized. The enzyme‐triggered delivery of NTPs was demonstrated by pig liver esterase, in human T‐lymphocyte cell extracts and by a polymerase chain reaction using a prodrug of thymidine triphosphate. The TriPPPro‐compounds of some HIV‐inactive nucleoside analogues showed marked anti‐HIV activity. For cellular uptake studies, a fluorescent TriPPPro‐compound was prepared that delivered the triphosphorylated metabolite to intact CEM cells.     

Asymmetric Synthesis of Polyhydroxy Pyrrolidinonyl Nucleoside Analogues from Tartaric acid

Modificationofnucleosideisanefficientproceduretodevelopnewpotentagentsagainsthumantum0r0rvirusesl.Morechallengingistosynthesizenew0pticallyactivepolyhydroxynucleosideanalogues.Becauseofthelimitationofresources,itseemsaratherardu0usworkt0synthesizeopticallyactivecarbocyclicorotherheterocyclicnucleosideanalogueswithmorethantwochiralcarb0ns,thoughnaturalsugarsareavaiIablestartingmaterialstooxa-cyclicnucleosides,suchasfuran0sylorpyranosylones.Inthispaper,wereportanefficientandgeneralsyntheticroute…     

New Nucleoside Analogues for the Treatment of Hemorrhagic Fever Virus Infections

Eight different compounds, all nucleoside analogues, could presently be considered as potential drug candidates for the treatment of Ebola virus (EBOV) and/or other hemorrhagic fever virus (HFV) infections. They can be considered as either (i) adenine analogues (3‐deazaneplanocin A, galidesivir, GS‐6620 and remdesivir) or (ii) guanine analogues containing the carboxamide entity (ribavirin, EICAR, pyrazofurin and favipiravir). All eight owe their mechanism of action to hydrogen bonded base pairing with either (i) uracil or (ii) cytosine. Four out of the eight compounds (galidesivir, GS‐6620, remdesivir and pyrazofurin) are C‐nucleosides, and two of them (GS‐6620, remdesivir) also contain a phosphoramidate part. The C‐nucleoside and phosphoramidate (and for the adenine analogues the 1′‐cyano group as well) may be considered as essential attributes for their antiviral activity.     

芳环缩合核苷衍生物的合成

A novel efficient synthetic route to 1,3-dihydrobenzo[c]furan glycone was developed and the corresponding 5-fluoro, 5-iodo uracil and guanosine derivatives, the aromatic analogues of the well known antiviral 2＇,3＇-dideoxy-2＇,3＇-dihydronucleosides （d4N）, were synthesized.     

Ring-Open Analogues of Adenine Nucleoside. Aminoacyl Derivatives of Cyclo- and Acyclo-Nucleosides

The synthesis of acyclic analogues of ribo- and deoxyribonucleosides is described. These compounds (Table 3) are both poor substrates and poor inhibitors of adenosine deaminase. The synthesis of dinucleotides from these analogues is also described, and the activity along with the inhibitory properties of some of them are studied against deaminase enzyme. These nucleotides are resistant to degradation by phosphodiesterases. HCl impregnated on silica gel is an excellent reagent for the preparation of the chloromethyl ether precursors of acyclo-nucleosides. A general and rapid procedure is developed for the preparation and isolation of the 5′-aminoacyl derivatives of robo- and arabinonucleosides. Quinoline has a marked effect on aminoacylations without racemization. Compounds 35a , b possess remarkable antiviral effects in vitro. A procedure is also developed for the conversion of acyclo-ribonucliosides 13e , f to acyclo-deoxyribonucleosides 11e , f .     

Synthesis of 1,2‐Disubstituted Carbocyclic Nucleoside Analogues of Cytidine

The synthesis of new 1,2‐disubstituted, five‐ or six‐ring‐carbocyclic nucleoside analogues of cytidine, compounds 1 and 2a – d , are described. These compounds were obtained by aminolysis, starting from the corresponding uracil derivative, via nucleophilic displacement of a triazolyl (Scheme 1) or a (2,4,6‐triisopropylphenyl)sulfonyl (TPS) group (Scheme 2) at 4‐position of the pyrimidine ring.     

Development of a blood-brain barrier model in a membrane-based microchip for characterization of drug permeability and cytotoxicity for drug screening

Since most of the central nervous system (CNS) drug candidates show poor permeability across the blood-brain barrier (BBB), development of a reliable platform for permeability assay will greatly accelerate drug discovery. Herein, we constructed a microfluidic BBB model to mimic drug delivery into the brain to induce cytotoxicity at target cells. To reconstitute the in vivo BBB properties, human cerebral microvessel endothelial cells (hCMEC/D3) were dynamically cultured in a membrane-based microchannel. Sunitinib, a model drug, was then delivered into the microchannel and forced to permeate through the BBB model. The permeated amount was directly quantified by an electrospray ionization quadrupole time-of-flight mass spectrometer (ESI-Q-TOF MS) after on-chip SPE (μSPE) pretreatment. Moreover, the permeated drug was incubated with glioma cells (U251) cultured inside agarose gel in the downstream to investigate drug-induced cytotoxicity. The resultant permeability of sunitinib was highly correlated with literature reported value, and it only required 30 min and 5 μL of sample solution for each permeation experiment. Moreover, after 48 h of treatment, the survival rate of U251 cells cultured in 3D scaffolds was nearly 6% higher than that in 2D, which was in accordance with the previously reported results. These results demonstrate that this platform provides a valid tool for drug permeability and cytotoxicity assays which have great value for the research and development of CNS drugs.     

微分脉冲伏安法用于血液中两种核苷类抗病毒药物的同时测定

采用微分脉冲伏安法考察了两种核苷类抗病毒药物阿昔洛韦(aciclovir)和喷昔洛韦(penciclovir)在乙二胺修饰的玻碳电极上的电化学行为及其在代谢血样中的同时测定方法,并探讨了电极修饰和电极反应的机理。在pH2.56的Britton-Robinson缓冲溶液中,阿昔洛韦和喷昔洛韦在乙二胺修饰的玻碳电极上均有一灵敏的不可逆氧化峰,峰电位分别为1.20和1.17 V。在优化的实验条件下,阿昔洛韦和喷昔洛韦分别在0.20~4.0 mg/L和0.02~0.40 mg/L浓度范围内与峰电流呈线性关系,其检出限分别为77和12μg/L。引入化学计量学方法对其混合组分的伏安谱进行解析,实现了两组分的同时测定,并对小鼠血液中代谢的两种核苷类抗病毒药物进行了同时测定。     

High-throughput prediction of blood-brain partitioning: a thermodynamic approach

A high-throughput in silico screening tool for potentially CNS active compounds was developed on the basis of the correlation of solvation free energies and blood-brain partitioning (log(cbrain/cblood) = log BB) data available from experimental sources. Utilizing a thermodynamic approach, solvation free energies were calculated by the fast and efficient generalized Born/surface area continuum solvation model, which enabled us to evaluate more than 10 compounds/min. Our training set involved a structurally diverse set of 55 compounds and yielded a function of log BB = 0.035Gsolv + 0.2592 (r = 0.85, standard error 0.37). Calculation of solvation free energies for 8700 CNS active compounds (CIPSLINE database) revealed that Gsolv is higher than -50 kJ/mol for the 96% of these compounds which can be used as suitable criteria for the identification of compounds preferable for CNS penetration.